Miller, Paul D <br/><br/>
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.  [electronic resource] 

 -  JAMA  Aug 2016 
 - 722-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2016.11136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--adverse effects<br/>Double-Blind Method<br/>Female<br/>Femur Neck--diagnostic imaging<br/>Humans<br/>Hypercalcemia--chemically induced<br/>Injections, Subcutaneous<br/>Lumbar Vertebrae--injuries<br/>Middle Aged<br/>Osteoporosis, Postmenopausal<br/>Osteoporotic Fractures--prevention & control<br/>Parathyroid Hormone-Related Protein--adverse effects<br/>Pelvic Bones--drug effects<br/>Placebos--therapeutic use<br/>Postmenopause<br/>Radiography<br/>Spinal Fractures--prevention & control<br/>Teriparatide--adverse effects<br/>Thoracic Vertebrae--injuries